Charles Flexner
Affiliations: | Johns Hopkins University, Baltimore, MD |
Area:
Medicine and Surgery, EpidemiologyGoogle:
"Charles Flexner"Children
Sign in to add trainee| Roberta R. Speck | grad student | 2002 | Johns Hopkins |
| Themba T. Ndovi | grad student | 2005 | Johns Hopkins |
| Todd T. Brown | grad student | 2007 | Johns Hopkins |
| Ying-Jun Cao | grad student | 2007 | Johns Hopkins |
| Myaing M. Nyunt | grad student | 2008 | Johns Hopkins |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Baim-Lance A, Cooley S, Yoo-Jeong M, et al. (2024) Current Challenges, Solutions, and Novel Directions in Research and Clinical Care: Proceedings from the 14th Annual International Workshop on HIV and Aging. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences |
| Shah NS, Kityo C, Hughes MD, et al. (2024) Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Delany-Moretlwe S, Flexner C, Bauermeister JA. (2023) Advancing use of long-acting and extended delivery HIV prevention and treatment regimens. Journal of the International Aids Society. e26126 |
| Flexner C. (2022) The future of long-acting agents for preexposure prophylaxis. Current Opinion in Hiv and Aids. 17: 192-198 |
| Flexner CW, Kashuba A. (2022) Editorial: New drugs for HIV: quo vadis? Current Opinion in Hiv and Aids. 17: 1-3 |
| Chandiwana NC, Serenata CM, Owen A, et al. (2021) Impact of long-acting therapies on the global HIV epidemic. Aids (London, England). 35: S137-S143 |
| Hurwitz SJ, Tao S, Gavegnano C, et al. (2021) Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agents Therapy from the ACTG A5336 Study. Journal of Clinical Pharmacology |
| Phillips AN, Bansi-Matharu L, Cambiano V, et al. (2021) The potential role of long-acting injectable cabotegravir-rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis. The Lancet. Global Health |
| Marconi VC, Moser C, Gavegnano C, et al. (2021) Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults with HIV. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Flexner C, Owen A, Siccardi M, et al. (2020) LONG-ACTING DRUGS AND FORMULATIONS FOR THE TREATMENT AND PREVENTION OF HIV. International Journal of Antimicrobial Agents. 106220 |